4/2/2020 We rallied a team of 30 volunteers to analyze 2500+ published papers in 11 days & extract data on dozens of drugs already tried for COVID19. This data is open source and intended to be used by physicians and to prioritize drugs for clinical trials.
As disease hunters who have identified and repurposed drugs for #Castleman disease, we are applying the #ChasingMyCure approach against COVID19. #ChasingCOVIDsCure. Check out our video here.
To learn more about how the Castleman Disease Collaborative Network (CDCN) and Center for Study & Treatment of inflammatory Lymphadenopathies (CSTL), under the leadership of Dr. David Fajgenbaum, are committed to the discovery of new uses for existing drugs to save patients’ lives, visit out drug repurposing page here.